Milestone Pharmaceuticals (MIST) announced that the Company granted equity awards, in the form of a total of 94,000 options to purchase the ...

Scotiabank analyst Patrick Colville maintained a Hold rating on Okta (OKTA – Research Report) today and set a price target of $109.00. The ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price target of ...

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target ...

Piper Sandler analyst David Westenberg maintained a Buy rating on Cytek Biosciences (CTKB – Research Report) today and set a price target of ...

In a report released today, David Westenberg from Piper Sandler maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Upstream Bio, Inc. (UPB – Research Report), with a ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on TransMedics Group (TMDX – Research Report) today and set a price target of ...

In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Natera (NTRA – Research Report), with a price target ...

Piper Sandler analyst David Westenberg maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $190.00.

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...